Literature DB >> 24857548

Gain-of-function mutant p53 promotes cell growth and cancer cell metabolism via inhibition of AMPK activation.

Ge Zhou1, Jiping Wang2, Mei Zhao2, Tong-Xin Xie2, Noriaki Tanaka2, Daisuke Sano2, Ameeta A Patel2, Alexandra M Ward2, Vlad C Sandulache2, Samar A Jasser2, Heath D Skinner2, Alison Lea Fitzgerald2, Abdullah A Osman2, Yongkun Wei3, Xuefeng Xia4, Zhou Songyang5, Gordon B Mills6, Mien-Chie Hung7, Carlos Caulin8, Jiyong Liang6, Jeffrey N Myers9.   

Abstract

Many mutant p53 proteins (mutp53s) exert oncogenic gain-of-function (GOF) properties, but the mechanisms mediating these functions remain poorly defined. We show here that GOF mutp53s inhibit AMP-activated protein kinase (AMPK) signaling in head and neck cancer cells. Conversely, downregulation of GOF mutp53s enhances AMPK activation under energy stress, decreasing the activity of the anabolic factors acetyl-CoA carboxylase and ribosomal protein S6 and inhibiting aerobic glycolytic potential and invasive cell growth. Under conditions of energy stress, GOF mutp53s, but not wild-type p53, preferentially bind to the AMPKα subunit and inhibit AMPK activation. Given the importance of AMPK as an energy sensor and tumor suppressor that inhibits anabolic metabolism, our findings reveal that direct inhibition of AMPK activation is an important mechanism through which mutp53s can gain oncogenic function.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24857548      PMCID: PMC4067806          DOI: 10.1016/j.molcel.2014.04.024

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  47 in total

1.  A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking.

Authors:  J M Stommel; N D Marchenko; G S Jimenez; U M Moll; T J Hope; G M Wahl
Journal:  EMBO J       Date:  1999-03-15       Impact factor: 11.598

2.  Mutant p53 facilitates pro-angiogenic, hyperproliferative phenotype in response to chronic relative hypoxia.

Authors:  Chandrashekhar D Kamat; Dixy E Green; Linda Warnke; Jessica E Thorpe; Antonio Ceriello; Michael A Ihnat
Journal:  Cancer Lett       Date:  2006-09-25       Impact factor: 8.679

3.  AMP-activated protein kinase induces a p53-dependent metabolic checkpoint.

Authors:  Russell G Jones; David R Plas; Sara Kubek; Monica Buzzai; James Mu; Yang Xu; Morris J Birnbaum; Craig B Thompson
Journal:  Mol Cell       Date:  2005-04-29       Impact factor: 17.970

4.  Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome.

Authors:  Kenneth P Olive; David A Tuveson; Zachary C Ruhe; Bob Yin; Nicholas A Willis; Roderick T Bronson; Denise Crowley; Tyler Jacks
Journal:  Cell       Date:  2004-12-17       Impact factor: 41.582

5.  Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome.

Authors:  Gene A Lang; Tomoo Iwakuma; Young-Ah Suh; Geng Liu; V Ashutosh Rao; John M Parant; Yasmine A Valentin-Vega; Tamara Terzian; Lisa C Caldwell; Louise C Strong; Adel K El-Naggar; Guillermina Lozano
Journal:  Cell       Date:  2004-12-17       Impact factor: 41.582

6.  Phosphorylation of rat muscle acetyl-CoA carboxylase by AMP-activated protein kinase and protein kinase A.

Authors:  W W Winder; H A Wilson; D G Hardie; B B Rasmussen; C A Hutber; G B Call; R D Clayton; L M Conley; S Yoon; B Zhou
Journal:  J Appl Physiol (1985)       Date:  1997-01

Review 7.  Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer.

Authors:  S Fogarty; D G Hardie
Journal:  Biochim Biophys Acta       Date:  2009-09-22

8.  The LKB1-AMPK pathway: metabolism and growth control in tumour suppression.

Authors:  David B Shackelford; Reuben J Shaw
Journal:  Nat Rev Cancer       Date:  2009-08       Impact factor: 60.716

Review 9.  Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase.

Authors:  D G Hardie; D A Pan
Journal:  Biochem Soc Trans       Date:  2002-11       Impact factor: 5.407

Review 10.  Understanding the Warburg effect: the metabolic requirements of cell proliferation.

Authors:  Matthew G Vander Heiden; Lewis C Cantley; Craig B Thompson
Journal:  Science       Date:  2009-05-22       Impact factor: 47.728

View more
  108 in total

Review 1.  Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention.

Authors:  Lisa M Butler; Ylenia Perone; Jonas Dehairs; Leslie E Lupien; Vincent de Laat; Ali Talebi; Massimo Loda; William B Kinlaw; Johannes V Swinnen
Journal:  Adv Drug Deliv Rev       Date:  2020-07-23       Impact factor: 15.470

Review 2.  TP53 Mutations in Head and Neck Squamous Cell Carcinoma and Their Impact on Disease Progression and Treatment Response.

Authors:  Ge Zhou; Zhiyi Liu; Jeffrey N Myers
Journal:  J Cell Biochem       Date:  2016-06-03       Impact factor: 4.429

Review 3.  Ceramide Signaling and p53 Pathways.

Authors:  Kristen A Jeffries; Natalia I Krupenko
Journal:  Adv Cancer Res       Date:  2018-06-01       Impact factor: 6.242

Review 4.  Li-Fraumeni Syndrome Disease Model: A Platform to Develop Precision Cancer Therapy Targeting Oncogenic p53.

Authors:  Ruoji Zhou; An Xu; Julian Gingold; Louise C Strong; Ruiying Zhao; Dung-Fang Lee
Journal:  Trends Pharmacol Sci       Date:  2017-08-14       Impact factor: 14.819

Review 5.  Oncogenic Mutant p53 Gain of Function Nourishes the Vicious Cycle of Tumor Development and Cancer Stem-Cell Formation.

Authors:  Yoav Shetzer; Alina Molchadsky; Varda Rotter
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

6.  Evolutionary Action Score of TP53 Coding Variants Is Predictive of Platinum Response in Head and Neck Cancer Patients.

Authors:  Abdullah A Osman; David M Neskey; Panagiotis Katsonis; Ameeta A Patel; Alexandra M Ward; Teng-Kuei Hsu; Stephanie C Hicks; Thomas O McDonald; Thomas J Ow; Marcus Ortega Alves; Curtis R Pickering; Heath D Skinner; Mei Zhao; Eric M Sturgis; Merrill S Kies; Adel El-Naggar; Federica Perrone; Lisa Licitra; Paolo Bossi; Marek Kimmel; Mitchell J Frederick; Olivier Lichtarge; Jeffrey N Myers
Journal:  Cancer Res       Date:  2015-02-17       Impact factor: 12.701

7.  Effect of Mutant p53 Proteins on Glycolysis and Mitochondrial Metabolism.

Authors:  Matilda Eriksson; Gorbatchev Ambroise; Amanda Tomie Ouchida; Andre Lima Queiroz; Dominique Smith; Alfredo Gimenez-Cassina; Marcin P Iwanicki; Patricia A Muller; Erik Norberg; Helin Vakifahmetoglu-Norberg
Journal:  Mol Cell Biol       Date:  2017-11-28       Impact factor: 4.272

8.  High-Risk TP53 Mutations Are Associated with Extranodal Extension in Oral Cavity Squamous Cell Carcinoma.

Authors:  Vlad C Sandulache; Chieko Michikawa; Jeffrey N Myers; Curtis R Pickering; Pranav Kataria; Frederico O Gleber-Netto; Diana Bell; Sanchit Trivedi; Xiayu Rao; Jing Wang; Mei Zhao; Samar Jasser
Journal:  Clin Cancer Res       Date:  2018-01-12       Impact factor: 12.531

Review 9.  Long non-coding RNAs involved in cancer metabolic reprogramming.

Authors:  Hui Liu; Junyun Luo; Siyu Luan; Chongsheng He; Zhaoyong Li
Journal:  Cell Mol Life Sci       Date:  2018-10-19       Impact factor: 9.261

10.  Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma.

Authors:  Frederico O Gleber-Netto; Mei Zhao; Sanchit Trivedi; Jiping Wang; Samar Jasser; Christina McDowell; Humam Kadara; Jiexin Zhang; Jing Wang; William N William; J Jack Lee; Minh Ly Nguyen; Sara I Pai; Heather M Walline; Dong M Shin; Robert L Ferris; Thomas E Carey; Jeffrey N Myers; Curtis R Pickering
Journal:  Cancer       Date:  2017-10-20       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.